{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:33:59Z","timestamp":1768836839773,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1280-6","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:03:07Z","timestamp":1560247387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Jan","family":"Haussmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balint","family":"Tamaskovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"B\u00f6lke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy-Joel","family":"Djiepmo-Njanang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Matuschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233\u201341.","journal-title":"N Engl J Med"},{"key":"1280_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567\u201375.","journal-title":"N Engl J Med"},{"key":"1280_CR3","first-page":"422","volume":"21","author":"T Horino","year":"1991","unstructured":"Horino T, Fujita M, Ueda N, et al. Efficacy of internal mammary node dissection in the treatment of breast cancer. Jpn J Clin Oncol. 1991;21:422\u20137.","journal-title":"Jpn J Clin Oncol"},{"key":"1280_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0167-8140(88)90003-5","volume":"11","author":"R Arriagada","year":"1988","unstructured":"Arriagada R, Le MG, Mouriesse H, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. 1988;11:213\u201322.","journal-title":"Radiother Oncol"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.radonc.2013.06.028","volume":"108","author":"A Courdi","year":"2013","unstructured":"Courdi A, Chamorey E, Ferrero JM, Hannoun-Levi JM. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients. Radiother Oncol. 2013;108:259\u201365.","journal-title":"Radiother Oncol"},{"key":"1280_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0360-3016(00)00526-5","volume":"47","author":"B Fowble","year":"2000","unstructured":"Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:883\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","volume":"12","author":"J Cuzick","year":"1994","unstructured":"Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447\u201353.","journal-title":"J Clin Oncol"},{"key":"1280_CR8","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"MGP Ebctcg","year":"2014","unstructured":"Ebctcg MGP, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127\u201335.","journal-title":"Lancet"},{"key":"1280_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast Cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918\u201326.","journal-title":"JAMA"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol"},{"key":"1280_CR11","doi-asserted-by":"crossref","unstructured":"Boekel NB, Jacobse JN, Schaapveld M, et al. Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer. Br J Cancer. 2018.","DOI":"10.1038\/s41416-018-0159-x"},{"key":"1280_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987\u201398.","journal-title":"N Engl J Med"},{"key":"1280_CR13","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.2017.77.6351","volume":"36","author":"C Taylor","year":"2018","unstructured":"Taylor C, McGale P, Bronnum D, et al. Cardiac structure injury after radiotherapy for breast Cancer: cross-sectional study with individual patient data. J Clin Oncol. 2018;36:2288\u201396.","journal-title":"J Clin Oncol"},{"key":"1280_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","volume":"35","author":"VA van den Bogaard","year":"2017","unstructured":"van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast Cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35:1171\u20138.","journal-title":"J Clin Oncol"},{"key":"1280_CR15","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ijrobp.2010.04.072","volume":"78","author":"R Jagsi","year":"2010","unstructured":"Jagsi R, Moran J, Marsh R, Masi K, Griffith KA, Pierce LJ. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys. 2010;78:1594\u2013603.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR16","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"1280_CR17","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815\u201334.","journal-title":"Stat Med"},{"key":"1280_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SA Doi","year":"2015","unstructured":"Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials. 2015;45:130\u20138.","journal-title":"Contemp Clin Trials"},{"key":"1280_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-7-5","volume":"7","author":"JO Friedrich","year":"2007","unstructured":"Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol. 2007;7:5.","journal-title":"BMC Med Res Methodol"},{"key":"1280_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Struikmans H, Bartelink H. Regional nodal irradiation in early-stage breast Cancer. N Engl J Med. 2015;373:1879\u201380.","journal-title":"N Engl J Med"},{"key":"1280_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ijrobp.2013.03.021","volume":"86","author":"C Hennequin","year":"2013","unstructured":"Hennequin C, Bossard N, Servagi-Vernat S, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86:860\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR22","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Levine MN. Regional nodal irradiation in early-stage breast Cancer. N Engl J Med. 2015;373:1878\u20139.","journal-title":"N Engl J Med"},{"key":"1280_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","volume":"34","author":"LB Thorsen","year":"2016","unstructured":"Thorsen LB, Offersen BV, Dano H, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast Cancer. J Clin Oncol. 2016;34:314\u201320.","journal-title":"J Clin Oncol"},{"key":"1280_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13014-015-0568-4","volume":"10","author":"W Budach","year":"2015","unstructured":"Budach W, Bolke E, Kammers K, Gerber PA, Nestle-Kramling C, Matuschek C. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update. Radiat Oncol. 2015;10:258.","journal-title":"Radiat Oncol"},{"key":"1280_CR25","doi-asserted-by":"crossref","unstructured":"Pazos M, Fiorentino A, Gaasch A, et al. Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold. Strahlenther Onkol. 2018.","DOI":"10.1007\/s00066-018-1350-y"},{"key":"1280_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ijrobp.2018.04.075","volume":"101","author":"R Jagsi","year":"2018","unstructured":"Jagsi R, Griffith KA, Moran JM, et al. A randomized comparison of radiation therapy techniques in the Management of Node-Positive Breast Cancer: primary outcomes analysis. Int J Radiat Oncol Biol Phys. 2018;101:1149\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1200\/JCO.2018.36.15_suppl.504","volume":"36","author":"P Poortmans","year":"2018","unstructured":"Poortmans P, Collette S, Struikmans H, et al. Fifteen-year results of the randomised EORTC trial 22922\/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. J Clin Oncol. 2018;36:504.","journal-title":"J Clin Oncol"},{"key":"1280_CR28","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.ejca.2014.04.033","volume":"50","author":"F Killander","year":"2014","unstructured":"Killander F, Anderson H, Kjellen E, Malmstrom P. Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy--25 year follow-up of a randomised trial from the South Sweden breast Cancer group. Eur J Cancer. 2014;50:2201\u201310.","journal-title":"Eur J Cancer"},{"key":"1280_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijrobp.2010.02.041","volume":"80","author":"EL Stokes","year":"2011","unstructured":"Stokes EL, Tyldesley S, Woods R, Wai E, Olivotto IA. Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:403\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR30","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMra065241","volume":"356","author":"RS Punglia","year":"2007","unstructured":"Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med. 2007;356:2399\u2013405.","journal-title":"N Engl J Med"},{"key":"1280_CR31","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol. 2014;32:3600\u20136.","journal-title":"J Clin Oncol"},{"key":"1280_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single Centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1280_CR33","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.ijrobp.2011.01.066","volume":"82","author":"L Yates","year":"2012","unstructured":"Yates L, Kirby A, Crichton S, et al. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes. Int J Radiat Oncol Biol Phys. 2012;82:2093\u2013103.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0360-3016(03)00017-8","volume":"56","author":"IS Grills","year":"2003","unstructured":"Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys. 2003;56:658\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ijrobp.2009.09.037","volume":"78","author":"JI Yu","year":"2010","unstructured":"Yu JI, Park W, Huh SJ, et al. Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer. Int J Radiat Oncol Biol Phys. 2010;78:1135\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijrobp.2004.06.006","volume":"61","author":"DR Reed","year":"2005","unstructured":"Reed DR, Lindsley SK, Mann GN, et al. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2005;61:358\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2004.04.065","volume":"61","author":"J Reznik","year":"2005","unstructured":"Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005;61:163\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1280_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/0284186X.2014.925579","volume":"53","author":"LB Thorsen","year":"2014","unstructured":"Thorsen LB, Thomsen MS, Berg M, et al. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects. Acta Oncol. 2014;53:1027\u201334.","journal-title":"Acta Oncol"},{"key":"1280_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41523-018-0061-y","volume":"4","author":"I Jatoi","year":"2018","unstructured":"Jatoi I, Benson JR, Kunkler I. Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality? NPJ Breast Cancer. 2018;4:8.","journal-title":"NPJ Breast Cancer"},{"key":"1280_CR40","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1200\/JCO.2017.72.7263","volume":"35","author":"M Sjostrom","year":"2017","unstructured":"Sjostrom M, Lundstedt D, Hartman L, et al. Response to radiotherapy after breast-conserving surgery in different breast Cancer subtypes in the Swedish breast Cancer group 91 radiotherapy randomized clinical trial. J Clin Oncol. 2017;35:3222\u20139.","journal-title":"J Clin Oncol"},{"key":"1280_CR41","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1200\/JCO.2014.57.7999","volume":"33","author":"FF Liu","year":"2015","unstructured":"Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal a breast Cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33:2035\u201340.","journal-title":"J Clin Oncol"},{"key":"1280_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","volume":"18","author":"JG Scott","year":"2017","unstructured":"Scott JG, Berglund A, Schell MJ, et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 2017;18:202\u201311.","journal-title":"Lancet Oncol"},{"key":"1280_CR43","doi-asserted-by":"crossref","unstructured":"Mignot F, Loirat D, Dureau S, et al. Disseminated tumor cells predict efficacy of regional nodal irradiation in early stage breast cancer. Int J Radiat Oncol Biol Phys. 2018.","DOI":"10.1016\/j.ijrobp.2018.09.033"},{"key":"1280_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0163","volume":"4","author":"CR Goodman","year":"2018","unstructured":"Goodman CR, Seagle BL, Friedl TWP, et al. Association of Circulating Tumor Cell Status with Benefit of radiotherapy and survival in early-stage breast Cancer. JAMA Oncol. 2018;4:e180163.","journal-title":"JAMA Oncol"},{"key":"1280_CR45","unstructured":"McDuff SGR, Mina AI, Brunelle CL, et al. Timing of lymphedema following treatment for breast Cancer: when are patients Most at-risk? Int J Radiat Oncol Biol Phys. 2018."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1280-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:26:15Z","timestamp":1591745175000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1280-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There was no ethics approval necessary because in this meta-analysis we were pulling numbers from the published manuscripts and pooling results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is a network-meta-analysis which does not contain any individual persons data, therefore not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"102"}}